MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Daily fluctuations of plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease

    K. Tarianyk, A. Shkodina (Poltava, Ukraine)

    Objective: The objective of this study is to compare evening and morning plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease (PD).…
  • MDS Virtual Congress 2021

    Parkinson’s disease patients with hallucinations exhibit dopaminergic degeneration and cortical thinning

    C. Wertz, K. Poston, N. Shaff, A. Hartman, A. Horner, A. Mayer, A. Vakhtin, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)

    Objective: Examine whether Parkinson’s disease patients (PD) who experience hallucinations (PD+hall) exhibit a greater decline in striatal dopamine and corresponding posterior cortical decline relative to…
  • MDS Virtual Congress 2021

    MOVEMENT DISORDERS IN CHILDREN WITH ATP1A3 GENE MUTATIONS. A SERIES OF CHILEAN PATIENTS

    M. Troncoso, D. Munoz, V. Naranjo, M. Matamala, J. Tello, S. Witting, A. Barrios, M. Hidalgo, I. Ruiz (Santiago, Chile)

    Objective: Describe the most frequent abnormal movements, their association with other symptoms, and the response to treatment in 4 children with ATP1A3 gene mutations. Background:…
  • MDS Virtual Congress 2021

    A novel tele-rehabilitation program aimed at reducing fall risk in Parkinson’s Disease patients

    M. Afshari, A. Hernandez, C. Goetz, J. Joyce (Chicago, USA)

    Objective: Our primary objective is to test the feasibility and preliminary efficacy of a novel falls-prevention program that uses videoconferencing technology to provide Parkinson’s Disease…
  • MDS Virtual Congress 2021

    Can telehealth support people with Parkinson’s disease to exercise at home?

    A. Flynn, C. Canning, E. Preston, S. Dennis, N. Allen (Bruce, Australia)

    Objective: To determine if telehealth physiotherapy can support people with Parkinson’s disease to transition from a clinic-based group exercise program to home-based exercise. Background: Exercise…
  • MDS Virtual Congress 2021

    Speaking with your hands in Parkinson’s: Investigating the rate and precision of co-speech gestures

    E. Poliakoff, M. Marciniak, A. Bettis, S. Humphries (Manchester, United Kingdom)

    Objective: To investigate the rate and precision of co-speech gestures produced by people with Parkinson’s as they describe self-produced actions. Background: Motor and cognitive impairments…
  • MDS Virtual Congress 2021

    Dysphagia in Hispanic patients with Parkinson’s disease – A single center 5-year retrospective chart review study

    E. Wang, F. Camarena, S. Schott (Chicago, USA)

    Objective: This five-year chart review study examined dysphagia in Hispanic patients with PD, specifically, the occurrence of dysphagia in Hispanic patients with PD that were…
  • MDS Virtual Congress 2021

    People living with Parkinson’s disease during the COVID-19 Pandemic: A cross-sectional survey of the Canadian experience

    M. Mckeown, T. Mestre, E. Crighton (Ottawa, Canada)

    Objective: To explore the how the COVID-19 pandemic has changed healthcare experiences for people living with Parkinson’s disease (PwP) in Canada. Background: Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Gait Improvement in Pegzilarginase-treated Patients With Arginase 1 Deficiency: A Blinded Kinematic Analysis

    N. Foreman, G. Bubb, E. Bradford (Colleyville, USA)

    Objective: To assess the impact of pegzilarginase therapy on gait kinematics in Arginase 1 Deficiency (ARG1-D) patients. Background: High arginine levels in patients with ARG1-D…
  • MDS Virtual Congress 2021

    Validation of the Thai version of the MDS-UPDRS

    P. Jagota, P. Srivanitchapoom, S. Petchrutchatachart, S. Singmaneesakulchai, A. Pisarnpong, P. Lolekha, S. Setthawatcharawanich, P. Chairangsaris, N. Limotai, P. Mekawichai, P. Panyakaew, O. Phokaewvarangkul, J. Sringean, N. Lapelle, P. Martinez-Martin, S. Luo, G. Stebbins, C. Goetz, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To validate the Thai translation of the MDS-sponsored revision of the UPDRS (MDS-UPDRS). Background: The MDS-UPDRS was published in 2008 to assess different domains…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley